Changes to the TSCA After 8 Years Webinar
Bergeson Campbell Webinar focuses on TSCA implementation challenges and accomplishments since the enactment of the Lautenberg Act amendments and where it stands now.
Source: natlawreview.com
Page 3 - Risk Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Risk Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Risk Evaluation Today - Breaking & Trending Today
Avadel to Present Data on Lumryz for Narcolepsy at SLEEP 2024
At SLEEP 2024, Avadel will present new data on Lumryz, the first extended-release, once-nightly formulation of sodium oxybate for narcolepsy.
Source: sleepreviewmag.com
United States - Securities - Northern District Of California Dismisses With Prejudice Putative Class Action Against Pharmaceutical Company
On May 7, 2024, Judge Beth Labson Freeman of the United States District Court for the Northern District of California dismissed with prejudice a putative shareholders' class action against a pharmaceutical company and certain of its executives...
Source: mondaq.com
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical benefit with median duration of response not reached and the majority of responders in...
Source: marketscreener.com
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma | Business
PRINCETON, N.J.--(BUSINESS WIRE)--May 15, 2024--
Source: valdostadailytimes.com